Evidence map›Paper›PMID 30152807›Full record

ArticleAnatolian journal of cardiology2018

The effect of rutin on cisplatin-induced oxidative cardiac damage in rats.

İsmail Topal, Aslı Özbek Bilgin, Ferda Keskin Çimen, Nezahat Kurt, Zeynep Süleyman, Yasin Bilgin, Adalet Özçiçek, Durdu Altuner

Open access · diamondAbstract read
In one paragraph

Article in Anatolian journal of cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. The effect of rutin on experimentally induced acute heart contusion in rats: Biochemical and histopathological evaluation.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Multiple Risk Factors for Heart Disease: A Challenge to the Ethnopharmacological Use ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

İsmail Topal
Aslı Özbek Bilgin
Ferda Keskin Çimen
Nezahat Kurt
Zeynep Süleyman
Yasin Bilgin
Adalet Özçiçek
Durdu AltunerDepartment of Pharmacology, Faculty of Medicine, Erzincan University; Erzincan-Turkey. durdualtuner@hotmail.com.
Erzincan University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCisplatin is an anticancer drug used for treating childhood solid tumors. Symptoms related to cisplatin-induced cardiovascular adverse effects may be mild or severe. Rutin (vitamin P1) has many properties, including as antioxidant, anticancer, antidiabetic, antimicrobial, antiulcer, and tissue renewal properties. Therefore, we aimed to biochemically, histopathologically, and immunohistochemically demonstrate the effect of rutin on cisplatin-induced cardiotoxicity in rats.

methodsThe rats included in our study were divided into four groups: Healthy group (HE), 5-mg/kg cisplatin group (CP), 50 mg/kg rutin+5-mg/kg cisplatin (CR-50), 100-mg/kg rutin+5-mg/kg cisplatin (CR-100) group.

resultsCP group administered cisplatin had significantly increased blood, serum, and cardiac tissue malondialdehyde (MDA), interleukin 1 beta (IL-1ß), tumor necrosis factor alpha (TNF-α), troponin I, creatine kinase (CK), and CK-MB levels compared to the HE group, whereas there was a significant decrease in the total glutathione (tGSH) levels. Rutin was observed to prevent the increase in MDA, IL-1ß, TNF-α, troponin I, CK, and CK-MB levels as well as prevent the decrease in tGSH levels more significantly when administered at a 100-mg/kg dose than at a 50-mg/kg dose. Histopathologically, cardiac necrosis, dilated/congested blood vessels, hemorrhage, polymorphonuclear leukocyte, edema, and cells with pyknotic nuclei were observed in the CP group. Rutin was shown to prevent cisplatin-induced cardiac damage more effectively when used at a100-mg/kg dose than at a 50-mg/kg dose.

conclusionThese results suggest that rutin is useful for preventing cisplatin-related cardiovascular damage.

Indexed as

AnimalsAntineoplastic AgentsAntioxidantsApoptosisCisplatinCreatine KinaseEdema, CardiacGlutathioneHeartHemorrhageInterleukin-1betaMaleMalondialdehydeNecrosisNeutrophilsOxidative StressAntineoplastic AgentsAntioxidantsCisplatinCreatine KinaseGlutathioneInterleukin-1betaMalondialdehydeRutinTroponin ITumor Necrosis Factor-alpha

Identifiers

PMID30152807
PMCPMC6237943
OpenAlexW2804625934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.